Clinical trial

Baricitinib in New-onset Type 1 Diabetes

NCT04774224

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-10-30

PhasePHASE2

Study timeline

Study start (actual)2020-10-30Date precision: day

Registry last updated2024-12-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

BaricitinibDRUG · verified · RxNorm: baricitinib

PlaceboDRUG

Sponsors & collaborators

St Vincent's Institute of Medical Researchlead sponsor

Juvenile Diabetes Research Foundation Australiacollaborator

Juvenile Diabetes Research Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04774224 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.